[MEP-28] Optimal Management of Thoracic Aortic Mobile Thrombus: Lessons From Clinical Cases

Thoracic aortic mobile thrombus (TAMT) is a rare and potentially life-threatening condition, often detected due to thromboembolic events. Early diagnosis has improved with advanced imaging modalities such as computed tomography and magnetic resonance imaging. However, no definitive treatment algorithm exists; options include medical management, hybrid approaches, endovascular therapy, and open surgery. This report discussed options in two TAMT patients at our center. In the first case, a 59-year-old female with diabetes and hypertension presented with back and flank pain. Computed tomography angiography revealed a 5.5-cm descending aortic thrombus, with additional splenic and renal infarcts. Emergency thoracic endovascular aortic repair was performed, successfully excluding the thrombus with no embolic events. The patient was discharged on anticoagulants and remained asymptomatic on follow-up. In the second case, a 44-year-old male without comorbidities presented with abdominal pain. Computed tomography angiography showed five descending aortic thrombi, with infarcts in the spleen and kidney. Catheter-directed thrombolysis was performed using alteplase. All thrombi lysed without complications, and the patient was discharged on anticoagulants. Followup imaging showed no residual thrombi. Thoracic aortic mobile thrombi can lead to severe complications, including systemic embolization and organ failure. Risk factors include hypercoagulability and conditions such as hypertension and diabetes. Treatment must be individualized based on thrombus location, patient condition, and center expertise. In our cases, thoracic endovascular aortic repair was chosen for a localized thrombus, while multilocation thrombi were managed with thrombolysis. Thrombolytic therapy requires careful monitoring of fibrinogen levels to minimize bleeding risk. With no current guideline directions, treatment should be tailored to the patient by weighing the risks and benefits of interventions based on individual patient factors and institutional resources.

Authors

Publication Details

Journal
Cardiovascular Surgery and Interventions
Published
2024-11-01
DOI
https://doi.org/10.5606/e-cvsi.2024.mep-28
Primary Topic
Aortic Thrombus and Embolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[MEP-28] Optimal Management of Thoracic Aortic Mobile Thrombus: Lessons From Clinical Cases

İsa Civelek, İlker İnce, Mehmet Emir Erol, Sertan Özyalçın
Cardiovascular Surgery and Interventions
Aortic Thrombus and Embolism
article

[MEP-28] Optimal Management of Thoracic Aortic Mobile Thrombus: Lessons From Clinical Cases

İsa Civelek, İlker İnce, Mehmet Emir Erol, Sertan Özyalçın
article en

Abstract

Thoracic aortic mobile thrombus (TAMT) is a rare and potentially life-threatening condition, often detected due to thromboembolic events. Early diagnosis has improved with advanced imaging modalities such as computed tomography and magnetic resonance imaging. However, no definitive treatment algorithm exists; options include medical management, hybrid approaches, endovascular therapy, and open surgery. This report discussed options in two TAMT patients at our center. In the first case, a 59-year-old female with diabetes and hypertension presented with back and flank pain. Computed tomography angiography revealed a 5.5-cm descending aortic thrombus, with additional splenic and renal infarcts. Emergency thoracic endovascular aortic repair was performed, successfully excluding the thrombus with no embolic events. The patient was discharged on anticoagulants and remained asymptomatic on follow-up. In the second case, a 44-year-old male without comorbidities presented with abdominal pain. Computed tomography angiography showed five descending aortic thrombi, with infarcts in the spleen and kidney. Catheter-directed thrombolysis was performed using alteplase. All thrombi lysed without complications, and the patient was discharged on anticoagulants. Followup imaging showed no residual thrombi. Thoracic aortic mobile thrombi can lead to severe complications, including systemic embolization and organ failure. Risk factors include hypercoagulability and conditions such as hypertension and diabetes. Treatment must be individualized based on thrombus location, patient condition, and center expertise. In our cases, thoracic endovascular aortic repair was chosen for a localized thrombus, while multilocation thrombi were managed with thrombolysis. Thrombolytic therapy requires careful monitoring of fibrinogen levels to minimize bleeding risk. With no current guideline directions, treatment should be tailored to the patient by weighing the risks and benefits of interventions based on individual patient factors and institutional resources.

Cardiovascular Surgery and InterventionsVol. 11(100)
Openalex Percentile: Top 55%
Aortic Thrombus and Embolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.